Analysts Hike Target Prices For Piramal Enterprises After Carlyle Deal

Analysts raised their target prices for Piramal Enterprises Ltd. after Carlyle Group agreed to pick up a stake in Ajay Piramal’s pharmaceutical business.The private equity fund will pay about $490 ...